UBS Lux Equity Fund Biotech USD vs BNP Paribas China Equity

UBS Lux Equity Fund Biotech USD vs BNP Paribas China Equity

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. BNP Paribas China Equity

  • Security

    BNP Paribas China Equity Classic USD Cap

  • Fee

    2.23%

  • ISIN

    LU0823426308

  • Holdings

    17

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with BNP Paribas China Equity, we have 18 holdings where Alibaba Group Holding Ltd is the largest holding (9.68), followed by Tencent (9.52) and Xiaomi (7.33).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and BNP Paribas China Equity.

UBS Lux Equity Fund Biotech USD BNP Paribas China Equity
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Alibaba Group Holding Ltd
China
9.68 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. Tencent Holdings Ltd
China
9.52 %
3. Moderna Inc
9.21 %
3. Xiaomi
China
7.33 %
4. Alnylam Pharmaceuticals Inc
6.54 %
4. Meituan Class B
China
5.29 %
5. AbbVie Inc
USA
5.52 %
5. Industrial and Commercial Bank of China Ltd Class H
China
4.58 %
6. Gilead Sciences Inc
USA
4.66 %
6. Ping An Insurance Co
China
4.2 %
7. Amgen Inc
4.32 %
7. JD.com Inc
China
3.02 %
8. BioNTech SE
4.13 %
8. NetEase ADR
China
3.01 %
9. Karuna Therapeutics Inc
3.75 %
9. Pinduoduo Inc
China
2.98 %
10. Royalty Pharma Plc
3.28 %
10. Taiwan Semiconductor Manufacturing Company
Taiwan
2.52 %
- 11. Pop Mart International Group Ltd
China
2.32 %
- 12. Trip.com Group Ltd
Singapore
1.96 %
- 13. KE Holdings Inc ADR
China
1.87 %
- 14. BeiGene Ltd
China
1.61 %
- 15. BYD Co Ltd Class H
China
1.59 %
- 16. Sunny Optical Technology Company Ltd
China
1.53 %
- 17. GDS Holdings Ltd ADR
China
1.22 %

The list of fund holdings was last updated on April 17, 2025.